Moreover, overexpression of PD-L1 and the chemokine receptor, DARC, have been reported to correlates with better prognosis among cancer cases, including CRC and particularly among MMR-proficient CRC patients [32, 33, 66]. This evidence concerns the gene ACKR1 and colorectal carcinoma.